Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
TriSalus Life Sciences, Inc. (TLSI) had Cash Flow from Investing Activities of $-0.14M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$8.90M |
|
$1.54M |
|
$1.23M |
|
$7.67M |
|
$17.31M |
|
$-8.41M |
|
$9.95M |
|
$1.54M |
|
$1.54M |
|
$1.55M |
|
$1.55M |
|
$1.54M |
|
$1.55M |
|
$-8.41M |
|
$-7.98M |
|
51.54M |
|
52.31M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$68.14M |
|
$1.94M |
|
$2.84M |
|
$70.98M |
|
$11.79M |
|
$33.08M |
|
$46.39M |
|
$58.17M |
|
$12.81M |
|
$12.81M |
|
$12.81M |
|
61.41M |
|
| Cash Flow Statement Financials | |
$-6.48M |
|
|
Cash Flow from Investing Activities |
$-0.14M |
$42.38M |
|
$20.79M |
|
$56.55M |
|
$35.76M |
|
$2.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.78 |
|
-- |
|
-- |
|
0.72 |
|
2.58 |
|
86.18% |
|
-94.52% |
|
-94.52% |
|
-- |
|
17.34% |
|
17.29% |
|
$-6.62M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.33 |
|
1.71 |
|
52.74 |
|
12.08% |
|
12.08% |
|
2.18% |
|
3.37% |
|
$0.21 |
|
$-0.13 |
|
$-0.12 |
|